Summary by Futu AI
On September 30, 2024, Intelligent Bio Solutions Inc. was the subject of a Schedule 13G filing with the United States Securities and Exchange Commission, indicating a change in ownership by certain entities and individuals. The filing was made by Lind Global Fund II LP, Lind Global Partners II LLC, and Jeff Easton, collectively referred to as the Reporting Persons. Each of the Reporting Persons reported beneficial ownership of 151,515 warrants to purchase common stock of Intelligent Bio Solutions, representing 3.4% of the company's class of securities. The warrants grant sole voting and dispositive power over the shares they may be converted into. The filing indicates that the ownership does not aim to change or influence the control of Intelligent Bio Solutions. The principal business office for the Reporting Persons is located at 444 Madison Ave, Floor 41, New York, NY 10022. The filing, which includes a joint filing agreement, was signed on November 14, 2024, by Jeff Easton, who is the managing member of Lind Global Partners II LLC and associated with Lind Global Fund II LP.
